Skip to main content
. 2021 Jan 4;116(6):1514–1520. doi: 10.1111/add.15324

Figure 3.

Figure 3

Number and rate (per 100 000 population) of pharmacy‐dispensed naloxone distribution in Ontario, stratified by opioid exposure group, July 2016–March 2020. (a) Prescription opioid agonist therapy recipients; (b) prescription opioid recipients; (c) people with past opioid exposure; (d) people with no/unknown opioid exposure. [Colour figure can be viewed at wileyonlinelibrary.com]